Additionally, Lp(a) recruits and activates inflammatory cells, further exacerbating plaque development. Clinical and population-based studies, including meta-analyses, have shown a positive correlation between Lp(a) levels and the risk of ASCVD. This evidence concerns the gene LPA and atherosclerosis.